Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome.

Saylors RL, Watkins B, Saccente S, Tang X.

Pediatr Blood Cancer. 2013 Dec;60(12):1952-6. doi: 10.1002/pbc.24744. Epub 2013 Sep 2.

PMID:
24000077
2.

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF.

Blood. 2012 Apr 19;119(16):3684-90. doi: 10.1182/blood-2011-05-349621. Epub 2011 Nov 17.

3.

Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).

Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW; ICA-17043-10 Study Investigators.

Br J Haematol. 2011 Apr;153(1):92-104. doi: 10.1111/j.1365-2141.2010.08520.x. Epub 2011 Feb 17.

PMID:
21323872
4.

Incidental findings on brain magnetic resonance imaging of children with sickle cell disease.

Jordan LC, McKinstry RC 3rd, Kraut MA, Ball WS, Vendt BA, Casella JF, DeBaun MR, Strouse JJ; Silent Infarct Transfusion Trial Investigators.

Pediatrics. 2010 Jul;126(1):53-61. doi: 10.1542/peds.2009-2800. Epub 2010 Jun 14.

5.

Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.

Stine KC, Saylors RL, Saccente S, McClain KL, Becton DL.

Pediatr Blood Cancer. 2004 Jul;43(1):81-4.

PMID:
15170896
6.

Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.

Maples HD, Stowe CD, Saccente SL, Jacobs RF.

Pediatr Infect Dis J. 2003 Nov;22(11):1022-4. No abstract available.

PMID:
14628778
7.

Long-term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexate.

Stine KC, Saylors RL, Saccente S, Becton DL.

Med Pediatr Oncol. 2003 Jul;41(1):77-8. No abstract available.

PMID:
12764753
8.

Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial.

Orringer EP, Casella JF, Ataga KI, Koshy M, Adams-Graves P, Luchtman-Jones L, Wun T, Watanabe M, Shafer F, Kutlar A, Abboud M, Steinberg M, Adler B, Swerdlow P, Terregino C, Saccente S, Files B, Ballas S, Brown R, Wojtowicz-Praga S, Grindel JM.

JAMA. 2001 Nov 7;286(17):2099-106.

PMID:
11694150
9.

Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia.

Jones AM, Seibert JJ, Nichols FT, Kinder DL, Cox K, Luden J, Carl EM, Brambilla D, Saccente S, Adams RJ.

Pediatr Radiol. 2001 Jul;31(7):461-9.

PMID:
11486797
10.

Comparison of attitudes about communication in children and adolescents with sickle cell disease.

Fuller J, Davis P, Dancer J, Gentry B, Montague J, Jackson J, Saccente S.

Percept Mot Skills. 1998 Oct;87(2):634.

PMID:
9842615
11.

Reading, writing, and vocabulary skills of children with strokes due to sickle cell disease.

Sanders C, Gentry B, Davis P, Jackson J, Saccente S, Dancer J.

Percept Mot Skills. 1997 Oct;85(2):477-8.

PMID:
9347531
12.

Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.

Saccente SL, Kohaut EC, Berkow RL.

Pediatr Nephrol. 1995 Oct;9(5):569-73.

PMID:
8580012

Supplemental Content

Loading ...
Support Center